Last reviewed · How we verify

NCT05637593

Rhythmic Auditory Stimulation on Upper-limb Movements in PD Patients

Not yet recruiting NA Last updated 10 April 2025
What this trial tests

NA trial testing Upper-limb movement training with the aid of RAS in Acoustic Stimulation in 138 participants. Not yet recruiting.

Timeline
1 June 2025
Primary endpoint
31 December 2026
31 December 2026

Quick facts

Lead sponsorThe Hong Kong Polytechnic University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment138
Start date1 June 2025
Primary completion31 December 2026
Estimated completion31 December 2026

Drugs / interventions tested

Conditions studied

Sponsor

The Hong Kong Polytechnic University

Who can join

18 and older, any sex, with Acoustic Stimulation or Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to examine effects of training involving rhythmic auditory stimulation (RAS) on upper-limb movements and functions in patients with Parkinson's disease (PD). This study employed a 21-day randomized controlled trial design to evaluate the efficacy of upper-limb training involving RAS on upper-limb function and neural activity in PD patients. The RAS group showed sustained improvements at one-month follow-up.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effects of training involving patterned sensory enhancement on improving upper-limb movements in patients with Parkinson's disease: protocol of a randomised controlled trial.
    Fan W, Fong KNK, Wang SM. · · 2023 · cited 1× · PMID 37438071 · DOI 10.1136/bmjopen-2023-072416

Verify or expand the search:

Other The Hong Kong Polytechnic University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05637593.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing